Partners in Progress: Cancer Patient Advocates and FDA

The objectives of this meeting are to provide basic training on the role of the FDA and new cancer patient advocates in oncology product development. This broad introduction to FDA regulatory aspects of oncology product development will be most relevant to attendees with limited knowledge and experience in cancer product development and patient advocacy.